{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T11:33:26Z","timestamp":1757590406830},"reference-count":116,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[1990,5,1]],"date-time":"1990-05-01T00:00:00Z","timestamp":641520000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Blut"],"published-print":{"date-parts":[[1990,5]]},"DOI":"10.1007\/bf01736225","type":"journal-article","created":{"date-parts":[[2005,6,13]],"date-time":"2005-06-13T15:59:47Z","timestamp":1118678387000},"page":"261-268","source":"Crossref","is-referenced-by-count":8,"title":["Current concepts for a drug-induced inhibition of formation and action of thromboxane A2"],"prefix":"10.1007","volume":"60","author":[{"given":"H.","family":"Patscheke","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"BF01736225_CR1","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/0014-2999(89)90715-2","volume":"165","author":"CL Armour","year":"1989","unstructured":"Armour CL, Johnson PRA, Alfredson ML, Black JL (1989) Characterization of contractile prostanoid receptors on human airway smooth muscle. Eur J Pharmacol 165: 215\u2013222","journal-title":"Eur J Pharmacol"},{"key":"BF01736225_CR2","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1111\/j.1476-5381.1983.tb10541.x","volume":"79","author":"RA Armstrong","year":"1983","unstructured":"Armstrong RA, Jones RL, Wilson NH (1983) Ligand binding to thromboxane receptors on human platelets: correlation with biological activity. Br J Pharmacol 79: 953\u2013964","journal-title":"Br J Pharmacol"},{"key":"BF01736225_CR3","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1016\/S0140-6736(85)92207-X","volume":"I","author":"M Beaufils","year":"1985","unstructured":"Beaufils M, Uzan S, Donsimoni R, Colau JC (1985) Prevention of preeclampsia by early antiplatelet therapy. Lancet I: 840\u2013842","journal-title":"Lancet"},{"key":"BF01736225_CR4","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1038\/ki.1988.162","volume":"34","author":"A Benigni","year":"1988","unstructured":"Benigni A, Chiabrando C, Piccinelli A, Perico N, Gavinelli M, Furci L, Patino O, Abbate M, Bertani T, Remuzzi G (1988) Increased urinary excretion of thromboxane B2 and 2,3-dinor-TxB2 in cyclosporin A nephrotoxicity. Kidney Internat 34: 164\u2013174","journal-title":"Kidney Internat"},{"key":"BF01736225_CR5","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.1182\/blood.V63.6.1460.1460","volume":"63","author":"V Bertele","year":"1984","unstructured":"Bertele V, Falanga A, Tomasiak M, Chiabrando C, Cerletti C, de Gaetano G (1984) Pharmacologic inhibition of thromboxane synthetase and platelet aggregation: modulatory role of cyclooxygenase products. Blood 63: 1460\u20131466","journal-title":"Blood"},{"key":"BF01736225_CR6","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1038\/315511a0","volume":"315","author":"SS Bhagwat","year":"1985","unstructured":"Bhagwat SS, Hamann PR, Still WC, Bunting S, Fitzpatrick FF (1985) Synthesis and structure of platelet aggregation factor thromboxane A2. Nature 315: 511\u2013513","journal-title":"Nature"},{"key":"BF01736225_CR7","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1111\/j.1476-5381.1989.tb11830.x","volume":"96","author":"RFG Booth","year":"1989","unstructured":"Booth RFG, Honey AC, Lad N, Tuffin DP, Wade PJ (1989) Inhibitory effect of a selective thromboxane A2 receptor antagonist, EP 092, on platelet aggregation in whole blood ex vivo and in vivo. Br J Pharmacol 96: 395\u2013405","journal-title":"Br J Pharmacol"},{"key":"BF01736225_CR8","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1021\/jm00384a012","volume":"30","author":"AG Brewster","year":"1987","unstructured":"Brewster AG, Caulkett PWR, Jessup R (1987) (5Z)-7-(2,2-dimethyl-4-phenyl-1,3-dioxan-cis-5-yl) heptenoic acid: a specific thromboxane A2 receptor antagonist. J Med Chem 30: 67\u201370","journal-title":"J Med Chem"},{"key":"BF01736225_CR9","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1161\/01.CIR.72.6.1208","volume":"72","author":"RT Brittain","year":"1985","unstructured":"Brittain RT, Boutal L, Carter MC, Coleman RA, Collington EW, Geisow HP, Hallett P, Hornby EJ, Humphrey PPA, Jack D, Kennedy I, Lumley P, McCabe PJ, Skidmore IF, Thomas M, Wallis CJ (1985) AH23848: a thromboxane receptor-blocking drug that can clarify the pathophysiologic role of thromboxane A2. Circulation 72: 1208\u20131218","journal-title":"Circulation"},{"key":"BF01736225_CR10","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1111\/j.1476-5381.1983.tb09393.x","volume":"78","author":"SE Burke","year":"1983","unstructured":"Burke SE, Lefer AM, Nicolaou KC, Smith GM, Smith JB (1983) Responsiveness of platelets and coronary arteries from different species to synthetic thromboxane and prostaglandin endoperoxide analogues. Br J Pharmacol 78: 287\u2013292","journal-title":"Br J Pharmacol"},{"key":"BF01736225_CR11","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/0049-3848(86)90012-5","volume":"44","author":"LR Bush","year":"1986","unstructured":"Bush LR, Smith SG (1986) Antagonism of U 46619-induced aggregation of human and canine platelets by four TxA2 receptor antagonists. Thromb Res 44: 377\u2013389","journal-title":"Thromb Res"},{"key":"BF01736225_CR12","doi-asserted-by":"crossref","first-page":"5861","DOI":"10.1073\/pnas.83.16.5861","volume":"83","author":"F Catella","year":"1986","unstructured":"Catella F, Healy D, Lawson J, FitzGerald GA (1986) 11-Dehydrothromboxane B2: an index of thromboxane formation in the human circulation. Proc Natl Acad Sci USA 83: 5861\u20135865","journal-title":"Proc Natl Acad Sci USA"},{"key":"BF01736225_CR13","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/0049-3848(80)90334-5","volume":"18","author":"AL Cerskus","year":"1980","unstructured":"Cerskus AL, Ali M, Davies BJ, McDonald JWD (1980) Possible significance of small numbers of functional platelets in a population of aspirin-treated platelets in vitro and in vivo. Thromb Res 18: 389\u2013397","journal-title":"Thromb Res"},{"key":"BF01736225_CR14","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1111\/j.1476-5381.1981.tb16814.x","volume":"73","author":"RA Coleman","year":"1981","unstructured":"Coleman RA, Humphrey PPA, Kennedy I, Levy GP, Lumley P (1981) Comparison of the actions of U-46,619, a prostaglandin H2-analog, with those of prostaglandin H2 and thromboxane A2 on some isolated smooth muscle preparations. Br J Pharmacol 73: 773\u2013778","journal-title":"Br J Pharmacol"},{"key":"BF01736225_CR15","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1111\/j.1476-5381.1989.tb11869.x","volume":"96","author":"RA Coleman","year":"1989","unstructured":"Coleman RA, Sheldrick RLG (1989) Prostanoid-induced contraction of human bronchial smooth muscle is mediated by TP-receptors. Br J Pharmacol 96: 688\u2013692","journal-title":"Br J Pharmacol"},{"key":"BF01736225_CR16","doi-asserted-by":"crossref","first-page":"3355","DOI":"10.1073\/pnas.72.9.3355","volume":"72","author":"EJ Corey","year":"1975","unstructured":"Corey EJ, Nicolaou KC, Machida Y, Malmsten CL, Samuelsson B (1975) Synthesis and biological properties of a 9,11-azoprostanoid: highly active biochemical mimic of prostaglandin endoperoxides. Proc Natl Acad Sci USA 72: 3355\u20133358","journal-title":"Proc Natl Acad Sci USA"},{"key":"BF01736225_CR17","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1055\/s-0038-1646524","volume":"61","author":"F Clerck De","year":"1989","unstructured":"De Clerck F, Beetens J, Van den Water A, Vercammen E, Janssen PAJ (1989) R 68070: Thromboxane A2 synthetase inhibition and thromboxane A2\/prostaglandin endoperoxide receptor blockade combined in one molecule \u2014 II. Pharmacological effects in vivo and ex vivo. Thromb Haemostas 61: 43\u201349","journal-title":"Thromb Haemostas"},{"key":"BF01736225_CR18","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/0049-3848(82)90311-5","volume":"26","author":"G Defreyn","year":"1982","unstructured":"Defreyn G, Deckmyn H, Vermylen J (1982) A thromboxane synthetase inhibitor reorients endoperoxide metabolism in whole blood towards prostacyclin and prostaglandin E2. Thromb Res 26: 389\u2013400","journal-title":"Thromb Res"},{"key":"BF01736225_CR19","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1182\/blood.V61.6.1081.1081","volume":"61","author":"G Minno Di","year":"1983","unstructured":"Di Minno G, Silver MJ, Murphy S (1983) Monitoring the entry of new platelets into the circulation after ingestion of aspirin. Blood 61: 1081\u20131085","journal-title":"Blood"},{"key":"BF01736225_CR20","first-page":"59","volume":"10","author":"GJ Dusting","year":"1982","unstructured":"Dusting GJ, Moncada S, Vane JR (1982) Prostacyclin: its biosynthesis, actions, and clinical potential. Adv Prostaglandin Thromboxane Leukotriene Res 10: 59\u2013106","journal-title":"Adv Prostaglandin Thromboxane Leukotriene Res"},{"key":"BF01736225_CR21","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1126\/science.959827","volume":"193","author":"EF Ellis","year":"1976","unstructured":"Ellis EF, Oelz O, Roberts LJ, Payne NA, Sweetman BJ, Nies AS, Oates JA (1976) Coronary arterial smooth muscle contraction by a substance released from platelets: evidence that it is thromboxane A2. Science 193: 1135\u20131137","journal-title":"Science"},{"key":"BF01736225_CR22","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1056\/NEJM198610163151602","volume":"315","author":"DJ Fitzgerald","year":"1986","unstructured":"Fitzgerald DJ, Roy L, Catella C, FitzGerald GA (1986) Platelet activation in unstable coronary heart disease. N Engl J Med 315: 983\u2013989","journal-title":"N Engl J Med"},{"key":"BF01736225_CR23","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/S0002-9378(87)80162-X","volume":"157","author":"DJ Fitzgerald","year":"1987","unstructured":"Fitzgerald DJ, Mayo G, Catella F, Entman SS, FitzGerald GA (1987) Increased thromboxane biosynthesis in normal pregnancy is mainly derived from platelets. Am J Obstet Gynecol 157: 325\u2013330","journal-title":"Am J Obstet Gynecol"},{"key":"BF01736225_CR24","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1161\/01.CIR.77.1.142","volume":"77","author":"DJ Fitzgerald","year":"1988","unstructured":"Fitzgerald DJ, Catella F, Roy L, FitzGerald GA (1988) Marked platelet activation in vivo after intravenous streptokinase in patients with acute myocardial infarction. Circulation 77: 142\u2013150","journal-title":"Circulation"},{"key":"BF01736225_CR25","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1172\/JCI111089","volume":"72","author":"GA FitzGerald","year":"1983","unstructured":"FitzGerald GA, Brash AR, Oates JA, Pedersen AK (1983) Endogenous prostacyclin biosynthesis and platelet function during selective inhibition of thromboxane synthase in man. J Clin Invest 72: 1336\u20131343","journal-title":"J Clin Invest"},{"key":"BF01736225_CR26","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1172\/JCI110814","volume":"71","author":"GA FitzGerald","year":"1983","unstructured":"FitzGerald GA, Oates JA, Hawiger J, Maas RL, Roberts LJ, Lawson JA, Brash AR (1983) Endogenous biosynthesis of prostaglandin and thromboxane and platelet function during chronic aspirin administration in man. J Clin Invest 71: 676\u2013688","journal-title":"J Clin Invest"},{"key":"BF01736225_CR27","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1056\/NEJM198404263101701","volume":"310","author":"GA FitzGerald","year":"1984","unstructured":"FitzGerald GA, Smith B, Pedersen AK, Brash AR (1984) Increased prostacyclin biosynthesis in patients with severe atherosclerosis and platelet activation. N Engl J Med 310: 1065\u20131068","journal-title":"N Engl J Med"},{"key":"BF01736225_CR28","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1038\/275764a0","volume":"275","author":"FA Fitzpatrick","year":"1978","unstructured":"Fitzpatrick FA, Bundy GL, Gorman RR (1978) 9,11-Epoxyiminoprosta-5,13-dienoic acid is a thromboxane A2 antagonist in human platelets. Nature (London) 275: 764\u2013766","journal-title":"Nature (London)"},{"key":"BF01736225_CR29","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/S0140-6736(81)90772-8","volume":"II","author":"ML Foegh","year":"1981","unstructured":"Foegh ML, Zmudka M, Cooley C, Winchester JF, Helfrich GB, Ramwell PW (1981) Urine-i-TxB2 in renal allograft rejection. Lancet II: 431\u2013434","journal-title":"Lancet"},{"key":"BF01736225_CR30","first-page":"269","volume":"54","author":"LT Friedhoff","year":"1985","unstructured":"Friedhoff LT, Manning J, Cooper W, Willard DA (1985) Effects of orally administered SQ28,668, a thromboxane A2\/prostaglandin endoperoxide antagonist on ex vivo platelet aggregation and bleeding time in healthy men. Thromb Haemostas 54: 269 (abstr)","journal-title":"Thromb Haemostas"},{"key":"BF01736225_CR31","first-page":"122","volume":"71","author":"SA Friedman","year":"1988","unstructured":"Friedman SA (1988) Preeclampsia: a review of the role of prostaglandins. Obstet Gynecol 71: 122\u2013137","journal-title":"Obstet Gynecol"},{"key":"BF01736225_CR32","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/0090-6980(77)90018-1","volume":"13","author":"RR Gorman","year":"1977","unstructured":"Gorman RR, Bunting S, Miller OV (1977) Modulation of human platelet adenylate cyclase by prostacyclin (PGX). Prostaglandins 13: 377\u2013388","journal-title":"Prostaglandins"},{"key":"BF01736225_CR33","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1016\/S0140-6736(84)92328-6","volume":"5","author":"P Gresele","year":"1984","unstructured":"Gresele P, Arnout J, Janssens W, Deckmyn H, Lemmens J, Vermylen J (1984) BM 13,177, a selective blocker of platelet and vessel wall thromboxane receptors, is active in man. Lancet, May 5: 991\u2013994","journal-title":"Lancet, May"},{"key":"BF01736225_CR34","doi-asserted-by":"crossref","first-page":"2083","DOI":"10.1016\/0006-2952(84)90577-X","volume":"33","author":"P Gresele","year":"1984","unstructured":"Gresele P, Deckmyn H, Huybrechts E, Vermylen J (1984) Serum albumin enhances the impairment of platelet aggregation with thromboxane synthase inhibition by increasing the formation of prostaglandin D2. Biochem Pharmacol 33: 2083\u20132088","journal-title":"Biochem Pharmacol"},{"key":"BF01736225_CR35","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1172\/JCI113223","volume":"87","author":"P Gresele","year":"1987","unstructured":"Gresele P, Arnout J, Deckmyn H, Huybrechts E, Pieters G, Vermylen J (1987) Role of proaggregatory and antiaggregatory prostaglandins in hemostasis. Studies with combined thromboxane synthase inhibition and thromboxane receptor antagonism. J Clin Invest 87: 1435\u20131445","journal-title":"J Clin Invest"},{"key":"BF01736225_CR36","first-page":"301","volume":"246","author":"P Gresele","year":"1988","unstructured":"Gresele P, Blockmans D, Deckmyn H, Vermylen J (1988) Adenylate cyclase activation determines the effect of thromboxane synthase inhibitors on platelet aggregation in vitro. Comparison of platelets from responders and nonresponders. J Pharm Exp Ther 246: 301\u2013307","journal-title":"J Pharm Exp Ther"},{"key":"BF01736225_CR37","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/0014-2999(87)90611-X","volume":"135","author":"RA Hall","year":"1987","unstructured":"Hall RA, Gillard J, Guindon Y, Letts G, Champion E, Ethier D, Evans J, Ford-Hutchinson AW, Fortin R, Jones TR, Lord A, Morton HE, Rokach J, Yoakim C (1987) Pharmacology of L-655,240 (3-(1-4-chlorobenzyl)-5-fluoro-3-methyl-indol-2-yl) 2,2-dimethylpropanoic acid); a potent, selective thromboxane\/prostaglandin endoperoxide antagonist. Eur J Pharmacol 135: 193\u2013201","journal-title":"Eur J Pharmacol"},{"key":"BF01736225_CR38","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1139\/y87-087","volume":"65","author":"RA Hall","year":"1987","unstructured":"Hall RA, Rokach JR, Belanger P, Bianchi L, Ethier D, Ford-Hutchinson AW, Girard Y, Hamel P, Hamel R, Lord A, Yusko P (1987) L-641,953 (R-8-fluoro-dibenzo(b,f)thiepin-3-carboxylic acid-5-oxide): a novel thromboxane-prostaglandin endoperoxide antagonist. Can J Physiol Pharmacol 65: 509\u2013514","journal-title":"Can J Physiol Pharmacol"},{"key":"BF01736225_CR39","doi-asserted-by":"crossref","first-page":"3400","DOI":"10.1073\/pnas.71.9.3400","volume":"71","author":"M Hamberg","year":"1974","unstructured":"Hamberg M, Samuelsson B (1974) Prostaglandin endoperoxides. Novel transformations of arachidonic acid in human platelets. Proc Natl Acad Sci USA 71: 3400\u20133404","journal-title":"Proc Natl Acad Sci USA"},{"key":"BF01736225_CR40","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1073\/pnas.71.2.345","volume":"71","author":"M Hamberg","year":"1974","unstructured":"Hamberg M, Svensson J, Wakabayashi T, Samuelsson B (1974) Isolation and structure of two prostaglandin endoperoxides that cause platelet aggregation. Proc Natl Acad Sci USA 71: 345\u2013349","journal-title":"Proc Natl Acad Sci USA"},{"key":"BF01736225_CR41","doi-asserted-by":"crossref","first-page":"2994","DOI":"10.1073\/pnas.72.8.2994","volume":"72","author":"M Hamberg","year":"1975","unstructured":"Hamberg M, Svensson J, Samuelsson B (1975) Thromboxanes: a new group of biologically active compounds derived from prostaglandin endoperoxides. Proc Natl Acad Sci USA 72: 2994\u20132998","journal-title":"Proc Natl Acad Sci USA"},{"key":"BF01736225_CR42","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1016\/S0735-1097(87)80336-4","volume":"10","author":"CW Hamm","year":"1987","unstructured":"Hamm CW, Lorenz RL, Bleifeld W, Kupper W, Wober W, Weber PC (1987) Biochemical evidence of platelet activation in patients with persistent unstable angina. J Am Coll Cardiol 10: 998\u20131004","journal-title":"J Am Coll Cardiol"},{"key":"BF01736225_CR43","doi-asserted-by":"crossref","first-page":"2007","DOI":"10.1016\/0006-2952(89)90501-7","volume":"38","author":"K Hanasaki","year":"1989","unstructured":"Hanasaki K, Nagasaki T, Arita H (1989) Characterization of platelet thromboxane A2\/prostaglandin H2 receptor by a novel thromboxane receptor antagonist, (3H)S-145. Biochem Pharmacol 38: 2007\u20132017","journal-title":"Biochem Pharmacol"},{"key":"BF01736225_CR44","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/0049-3848(80)90387-4","volume":"20","author":"S Heptinstall","year":"1980","unstructured":"Heptinstall S, Bevan J, Cockbill SR, Hanley SP, Parry MJ (1980) Effects of a selective inhibitor of thromboxane synthetase on human blood platelet behaviour. Thromb Res 20: 219\u2013230","journal-title":"Thromb Res"},{"key":"BF01736225_CR45","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1056\/NEJM198103193041201","volume":"304","author":"PD Hirsh","year":"1981","unstructured":"Hirsh PD, Hillis LD, Campbell WB, Firth BG, Willerson JT (1981) Release of prostaglandins and thromboxane into the coronary circulation in patients with ischemic heart disease. N Engl J Med 304: 685\u2013691","journal-title":"N Engl J Med"},{"key":"BF01736225_CR46","doi-asserted-by":"crossref","unstructured":"Hirsh J, Salzman EW, Harker L, Fuster V, Dalen JE, Cairns JA, Collins R (1989) Aspirin and other platelet active drugs. Relationship among dose, effectiveness, and side effects. Chest 95: 12S\u201318S","DOI":"10.1378\/chest.95.2.12S"},{"key":"BF01736225_CR47","first-page":"241","volume":"2","author":"W Hornberger","year":"1989","unstructured":"Hornberger W, Patscheke H (1989) Transient concentrations and agonist potency of PGH2 in human platelet activation. Eicosanoids 2: 241\u2013248","journal-title":"Eicosanoids"},{"key":"BF01736225_CR48","first-page":"567","volume":"27","author":"W Hornberger","year":"1989","unstructured":"Hornberger W, Patscheke H (1989) Hydrogen peroxide and methyl mercury are primary stimuli of eicosanoid release in human platelets. J Clin Chem Clin Biochem 27: 567\u2013575","journal-title":"J Clin Chem Clin Biochem"},{"key":"BF01736225_CR49","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1055\/s-0038-1646609","volume":"61","author":"EJ Hornby","year":"1989","unstructured":"Hornby EJ, Foster MR, McCabe PJ, Stratton LE (1989) The inhibitory effect of GR32191, a thromboxane receptor blocking drug, on human platelet aggregation, adhesion and secretion. Thromb Haemostas 61: 429\u2013436","journal-title":"Thromb Haemostas"},{"key":"BF01736225_CR50","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1016\/0006-2952(82)90359-8","volume":"31","author":"EJ Hornby","year":"1982","unstructured":"Hornby EJ, Skidmore IF (1982) Evidence that prostaglandin endoperoxides can induce platelet aggregation in the absence of thromboxane A2 production. Biochem Pharmacol 31: 1158\u20131160","journal-title":"Biochem Pharmacol"},{"key":"BF01736225_CR51","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/0090-6980(82)90145-9","volume":"24","author":"SC Hung","year":"1982","unstructured":"Hung SC, Chali NI, Venton DL, Le Breton GC (1982) Prostaglandin F2\u03b1 antagonizes thromboxane A2-induced human platelet aggregation. Prostaglandins 24: 195\u2013206","journal-title":"Prostaglandins"},{"key":"BF01736225_CR52","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1042\/bj2040003","volume":"204","author":"RL Irvine","year":"1982","unstructured":"Irvine RL (1982) How is the level of free arachidonic acid controlled in mammalian cells. Biochem J 204: 3\u201316","journal-title":"Biochem J"},{"key":"BF01736225_CR53","first-page":"349","volume":"II","author":"Isis-2 (Second International Study of Infarct Survival) Collaboratory Group","year":"1988","unstructured":"Isis-2 (Second International Study of Infarct Survival) Collaboratory Group (1988) Randomized trial of intravenous streptokinase, oral aspirin, both, or neither among 17 187 cases of suspected acute myocardial infarction: Isis-2. Lancet II: 349\u2013361","journal-title":"Lancet"},{"key":"BF01736225_CR54","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/0262-1746(83)90046-X","volume":"11","author":"RL Jones","year":"1983","unstructured":"Jones RL, Wilson NH, Armstrong RA, Peesapati V, Smith GM (1983) Effects of the thromboxane antagonist EP 045 on platelet aggregation. Adv Prostaglandin Thromboxane Leukotriene Res 11: 345\u2013350","journal-title":"Adv Prostaglandin Thromboxane Leukotriene Res"},{"key":"BF01736225_CR55","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1016\/0049-3848(80)90007-9","volume":"19","author":"KA Jorgensen","year":"1980","unstructured":"Jorgensen KA, Dyerberg J, Olesen AS, Stoffersen E (1980) Acetylsalicylic acid, bleeding time and age. Thromb Res 19: 799\u2013805","journal-title":"Thromb Res"},{"key":"BF01736225_CR56","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/0049-3848(87)90224-6","volume":"45","author":"R Kallmann","year":"1987","unstructured":"Kallmann R, Nieuwenhuis HK, de Groot PG, van Gijn J, Sixma JJ (1987) Effects of low doses of aspirin, 10 mg and 30 mg daily, on bleeding time, thromboxane production and 6-keto-PGF1\u03b1 excretion in healthy subjects. Thromb Res 45: 355\u2013361","journal-title":"Thromb Res"},{"key":"BF01736225_CR57","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1016\/0090-6980(82)90036-3","volume":"24","author":"I Kennedy","year":"1982","unstructured":"Kennedy I, Coleman RA, Humphrey PPA, Levy GP, Lumley P (1982) Studies on the characterization of prostanoid receptors: a proposed classification. Prostaglandins 24: 667\u2013689","journal-title":"Prostaglandins"},{"key":"BF01736225_CR58","unstructured":"Kerins DM, Roy L, FitzGerald GA, Fitzgerald DJ (1988) Evidence of platelet activation during coronary thrombolysis with tissue plasminogen activator in man. Clin Res 36: 4A (abstr)"},{"key":"BF01736225_CR59","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1056\/NEJM198604103141501","volume":"314","author":"HR Knapp","year":"1986","unstructured":"Knapp HR, Reilly IAG, Alessandrini P, FitzGerald GA (1986) Dietary fish oil alters in vivo indices of platelet and vascular function in human atherosclerosis. N Engl J Med 314: 937\u2013942","journal-title":"N Engl J Med"},{"key":"BF01736225_CR60","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/0049-3848(88)90267-8","volume":"50","author":"HR Knapp","year":"1988","unstructured":"Knapp HR, Healy C, Lawson J, FitzGerald GA (1988) Effects of low-dose aspirin on endogenous eicosanoid formation in normal and atherosclerotic men. Thromb Res 50: 377\u2013386","journal-title":"Thromb Res"},{"key":"BF01736225_CR61","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/0014-2999(89)90194-5","volume":"163","author":"K Kondo","year":"1989","unstructured":"Kondo K, Seo R, Naka M, Kitagawa T, Wakitani K, Sakata M, Kira H, Okegawa T, Kawasaki A (1989) Effects of ONO-3708, an antagonist of the thromboxane A2\/prostaglandin endoperoxide receptor, on platelet aggregation and thrombosis. Eur J Pharmacol 163: 253\u2013261","journal-title":"Eur J Pharmacol"},{"key":"BF01736225_CR62","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1161\/01.CIR.75.5.1025","volume":"75","author":"PA Kyrle","year":"1987","unstructured":"Kyrle PA, Eichler HG, Jager U, Lechner K (1987) Inhibition of prostaglandin and thromboxane A2 generation by low-dose aspirin at the site of plug formation in man in vivo. Circulation 75: 1025\u20131029","journal-title":"Circulation"},{"key":"BF01736225_CR63","doi-asserted-by":"crossref","first-page":"4097","DOI":"10.1073\/pnas.76.8.4097","volume":"76","author":"GC Breton Le","year":"1979","unstructured":"Le Breton GC, Venton DL, Enke SE, Halushka PV (1979) 13-Azaprostanoid acid: specific antagonist of the human blood platelet thromboxane\/endoperoxide receptor. Proc Natl Acad Sci USA 76: 4097\u20134100","journal-title":"Proc Natl Acad Sci USA"},{"key":"BF01736225_CR64","doi-asserted-by":"crossref","first-page":"1706","DOI":"10.1073\/pnas.77.3.1706","volume":"77","author":"AM Lefer","year":"1980","unstructured":"Lefer AM, Smith EF III, Araki H, Smith JB, Aharony D, Claremon DA, Magolda RL, Nicolaou KC (1980) Dissociation of vasoconstrictor and platelet aggregatory activities of thromboxane by carbocyclic thromboxane A2, a stable analog of thromboxane A2. Proc Natl Acad Sci USA 77: 1706\u20131710","journal-title":"Proc Natl Acad Sci USA"},{"key":"BF01736225_CR65","first-page":"1133","volume":"247","author":"N Liel","year":"1988","unstructured":"Liel N, Mais DE, Halushka PV (1988) Desensitization of platelet thromboxane A2\/prostaglandin H2 receptors by the mimetic U46619. J Pharmacol Exp Ther 247: 1133\u20131138","journal-title":"J Pharmacol Exp Ther"},{"key":"BF01736225_CR66","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1016\/S0140-6736(84)92446-2","volume":"I","author":"RL Lorenz","year":"1984","unstructured":"Lorenz RL, Weber M, Kotzur J, Theisen K, Schacky CV, Meister W, Reichard B, Weber PC (1984) Improved aortocoronary bypass patency by low-dose aspirin (100 mg daily): effects on platelet aggregation and thromboxane formation. Lancet I: 1261\u20131264","journal-title":"Lancet"},{"key":"BF01736225_CR67","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1111\/j.1476-5381.1989.tb12017.x","volume":"97","author":"P Lumley","year":"1989","unstructured":"Lumley P, White BP, Humphrey PPA (1989) GR32191, a highly potent and specific thromboxane A2 receptor blocking drug on platelets and vascular and airways smooth muscle in vitro. Br J Pharmacol 97: 783\u2013794","journal-title":"Br J Pharmacol"},{"key":"BF01736225_CR68","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/0014-2999(85)90121-9","volume":"111","author":"DE Mais","year":"1985","unstructured":"Mais DE, Dunlap C, Hamanaka N, Halushka P (1985) Further studies on the effects of epimers of thromboxane A2 antagonists on platelets and veins. Eur J Pharmacol 111: 125\u2013128","journal-title":"Eur J Pharmacol"},{"key":"BF01736225_CR69","first-page":"418","volume":"233","author":"DE Mais","year":"1985","unstructured":"Mais DE, Saussy D, Chaikhouni A, Kochel P, Knapp D, Hamanaka N, Halushka P (1985) Pharmacologic characterization of human and canine thromboxane A2\/prostaglandin H2 receptors in platelets and blood vessels: evidence for different receptors. J Pharmacol Exp Ther 233: 418\u2013424","journal-title":"J Pharmacol Exp Ther"},{"key":"BF01736225_CR70","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/0014-2999(88)90108-2","volume":"148","author":"DE Mais","year":"1988","unstructured":"Mais DE, DeHoll D, Sightler H, Halushka PV (1988) Different pharmacologic activities for 13-azapinane thromboxane A2 analogs in platelets and blood vessels. Eur J Pharmacol 148: 309\u2013315","journal-title":"Eur J Pharmacol"},{"key":"BF01736225_CR71","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1016\/S0140-6736(79)92334-1","volume":"II","author":"G Masotti","year":"1979","unstructured":"Masotti G, Galanti G, Poggesi L, Abbate R, Neri-Serneri GG (1979) Differential inhibition of prostacyclin production and platelet aggregation by aspirin. Lancet II: 1213\u20131217","journal-title":"Lancet"},{"key":"BF01736225_CR72","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1016\/S0006-291X(88)80311-5","volume":"157","author":"PR Mayeux","year":"1988","unstructured":"Mayeux PR, Morton HE, Gillard J, Lord A, Morinelli TA, Boehm A, Mais DE, Halushka PV (1988) The affinities of prostaglandin H2 and thromboxane A2 for their receptor are similar in washed human platelets. Biochem Biophys Res Commun 157: 733\u2013739","journal-title":"Biochem Biophys Res Commun"},{"key":"BF01736225_CR73","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1016\/S0735-1097(84)80410-6","volume":"4","author":"JL Mehta","year":"1984","unstructured":"Mehta JL, Mehta P, Lopez L, Ostrowski N, Aguila E (1984) Platelet function and biosynthesis of prostacyclin and thromboxane A2 in whole blood after aspirin administration in human subjects. J Amer Coll Cardiol 4: 806\u2013811","journal-title":"J Amer Coll Cardiol"},{"key":"BF01736225_CR74","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/0014-2999(89)90086-1","volume":"160","author":"S Mihara","year":"1989","unstructured":"Mihara S, Hara S, Ueda M, Ide M, Fujimoto M (1989) Comparison of vascular and platelet thromboxane A2\/prostaglandin H2 receptors in the pig. Eur J Pharmacol 160: 313\u2013321","journal-title":"Eur J Pharmacol"},{"key":"BF01736225_CR75","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/0049-3848(74)90176-5","volume":"5","author":"DC Mills","year":"1974","unstructured":"Mills DC, Macfarlane DE (1974) Stimulation of human platelet adenylate cyclase by prostaglandin D2. Thromb Res 5: 401\u2013412","journal-title":"Thromb Res"},{"key":"BF01736225_CR76","first-page":"293","volume":"30","author":"S Moncada","year":"1979","unstructured":"Moncada S, Vane JR (1979) Pharmacology and endogenous roles of prostaglandin endoperoxides, thromboxane A2, and prostacyclin. Pharmacol Rev 30: 293\u2013331","journal-title":"Pharmacol Rev"},{"key":"BF01736225_CR77","doi-asserted-by":"crossref","first-page":"5600","DOI":"10.1073\/pnas.86.14.5600","volume":"86","author":"TA Morinelli","year":"1989","unstructured":"Morinelli TA, Okwu AK, Mais DE, Halushka PV, John V, Chen C-K, Fried J (1989) Difluorothromboxane A2 and stereoisomers: stable derivatives of thromboxane A2 with differential effects on platelets and blood vessels. Proc Natl Acad Sci USA 86: 5600\u20135604","journal-title":"Proc Natl Acad Sci USA"},{"key":"BF01736225_CR78","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1159\/000411185","volume-title":"Prostaglandins and other eicosanoids in the cardiovascular system","author":"B M\u00fcller-Beckmann","year":"1985","unstructured":"M\u00fcller-Beckmann B, Stegmeier K, Sponer G, Patscheke H (1985) The non-prostanoid BM 13,177 inhibits vasoconstriction at the thromboxane receptor level. In: Schr\u00f6r K (ed) Prostaglandins and other eicosanoids in the cardiovascular system. Karger, Basel, pp 480\u2013484"},{"key":"BF01736225_CR79","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1126\/science.945611","volume":"193","author":"P Needleman","year":"1976","unstructured":"Needleman P, Minkes M, Raz A (1976) Thromboxanes: selective biosynthesis and distinct biological properties. Science 193: 163\u2013165","journal-title":"Science"},{"key":"BF01736225_CR80","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1038\/261558a0","volume":"261","author":"P Needleman","year":"1976","unstructured":"Needleman P, Moncada S, Bunting S, Vane JR, Hamberg M, Samuelsson B (1976) Identification of an enzyme in platelet microsomes which generates thromboxane A2 from prostaglandin endoperoxides. Nature 261: 558\u2013560","journal-title":"Nature"},{"key":"BF01736225_CR81","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1172\/JCI113895","volume":"83","author":"J Nowak","year":"1989","unstructured":"Nowak J, FitzGerald GA (1989) Redirection of prostaglandin endoperoxide metabolism at the platelet-vascular interface in man. J Clin Invest 83: 380\u2013385","journal-title":"J Clin Invest"},{"key":"BF01736225_CR82","first-page":"1029","volume":"54","author":"J Nowak","year":"1985","unstructured":"Nowak J, Murray J, Oates JA, FitzGerald GA (1985) Platelet function and the in vivo formation of thromboxane A2 and prostacyclin during chronic smoking and withdrawal in man. Thromb Haemostas 54: 1029","journal-title":"Thromb Haemostas"},{"key":"BF01736225_CR83","first-page":"435","volume":"234","author":"ML Ogletree","year":"1985","unstructured":"Ogletree ML, Harris DN, Greenberg R, Haslanger MF, Nakane M (1985) Pharmacological actions of SQ 29,548, a novel selective thromboxane antagonist. J Pharmacol Exp Ther 234: 435\u2013441","journal-title":"J Pharmacol Exp Ther"},{"key":"BF01736225_CR84","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1172\/JCI110576","volume":"69","author":"P Patrignani","year":"1982","unstructured":"Patrignani P, Filabozzi P, Patrono C (1982) Selective cumulative inhibition of platelet thromboxane production by low-dose aspirin in healthy subjects. J Clin Invest 69: 1366\u20131372","journal-title":"J Clin Invest"},{"key":"BF01736225_CR85","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1172\/JCI112053","volume":"76","author":"C Patrono","year":"1985","unstructured":"Patrono C, Ciabattoni G, Remuzzi G, Gott E, Bombardieri S, Di Munno O, Tartarelli G, Cinotti GA, Simonetti BM, Pierucci A (1985) Functional significance of renal prostacyclin and thromboxane A2 production in patients with systemic lupus erythematosus. J Clin Invest 76: 1011\u20131018","journal-title":"J Clin Invest"},{"key":"BF01736225_CR86","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1172\/JCI112341","volume":"77","author":"C Patrono","year":"1986","unstructured":"Patrono C, Ciabattoni G, Pugliese F, Pierucci A, Blair IA, FitzGerald GA (1986) Estimated rate of thromboxane secretion into the circulation of normal man. J Clin Invest 77: 590\u2013594","journal-title":"J Clin Invest"},{"key":"BF01736225_CR87","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/ki.1987.164","volume":"32","author":"C Patrono","year":"1987","unstructured":"Patrono C, Dunn MJ (1987) The clinical significance of inhibition of renal prostaglandin synthesis. Kidney Int 32: 1\u201312","journal-title":"Kidney Int"},{"key":"BF01736225_CR88","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1016\/0006-2952(85)90488-5","volume":"34","author":"H Patscheke","year":"1985","unstructured":"Patscheke H (1985) Thromboxane synthase inhibition potentiates washed platelet activation by endogenous or exogenous arachidonic acid. Biochem Pharmacol 34: 1151\u20131156","journal-title":"Biochem Pharmacol"},{"key":"BF01736225_CR89","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/0049-3848(84)90163-4","volume":"33","author":"H Patscheke","year":"1984","unstructured":"Patscheke H, Stegmeier K (1984) Investigations on a selective non-prostanoic thromboxane antagonist, BM 13,177, in human platelets. Thromb Res 33: 277\u2013288","journal-title":"Thromb Res"},{"key":"BF01736225_CR90","first-page":"371","volume-title":"Platelets, prostaglandins, and the cardiovascular system","author":"H Patscheke","year":"1985","unstructured":"Patscheke H, Stegmeier K (1985) Effects of the prostaglandin H2\/thromboxane A2 antagonist BM 13,177 on human platelets. In: Neri Serneri GG, McGiff JC, Paoletti R, Born GVR (eds) Platelets, prostaglandins, and the cardiovascular system. Raven Press, New York, pp 371\u2013373"},{"key":"BF01736225_CR91","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1038\/clpt.1986.25","volume":"39","author":"H Patscheke","year":"1986","unstructured":"Patscheke H, Staiger C, Neugebauer G, Kaufmann B, Strein K, Endele R, Stegmeier K (1986) The pharmacokinetic and pharmacodynamic profile of the thromboxane A2 receptor blocker BM 13,177. Clin Pharmacol Ther 39: 145\u2013156","journal-title":"Clin Pharmacol Ther"},{"key":"BF01736225_CR92","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1084\/jem.158.2.393","volume":"158","author":"NA Pawlowski","year":"1983","unstructured":"Pawlowski NA, Kaplan G, Hamill AL, Cohn ZA, Scott WA (1983) Arachidonic acid metabolism by human monocytes. Studies with platelet-depleted cultures. J Exp Med 158: 393","journal-title":"J Exp Med"},{"key":"BF01736225_CR93","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1056\/NEJM198411083111902","volume":"311","author":"AK Pedersen","year":"1984","unstructured":"Pedersen AK, Fitzgerald GA (1984) Dose-related kinetics of aspirin: presystemic acetylation of platelet cyclo-oxygenase. N Engl J Med 311: 1206\u20131211","journal-title":"N Engl J Med"},{"key":"BF01736225_CR94","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0002-8703(86)90544-2","volume":"111","author":"MB Peterson","year":"1986","unstructured":"Peterson MB, Machaj V, Block PC, Palacios I, Philbin D, Watkins D (1986) Thromboxane release during percutaneous transluminal coronary angioplasty. Am Heart J 111: 1\u20136","journal-title":"Am Heart J"},{"key":"BF01736225_CR95","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1056\/NEJM198902163200703","volume":"320","author":"A Pierucci","year":"1989","unstructured":"Pierucci A, Simonetti BM, Pecci G, Mavrikakis G, Feriozzi S, Cinotti GA, Patrignani P, Ciabattoni G, Patrono C (1989) Improvement of renal function with selective thromboxane antagonism in lupus nephritis. New Engl J Med 320: 421\u2013425","journal-title":"New Engl J Med"},{"key":"BF01736225_CR96","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1056\/NEJM198101083040203","volume":"304","author":"FE Preston","year":"1981","unstructured":"Preston FE, Whipps S, Jackson CA, French AJ, Wyld PJ, Stoddard CJ (1981) Inhibition of prostacyclin and platelet thromboxane A2 after low-dose aspirin. N Engl J Med 304: 76","journal-title":"N Engl J Med"},{"key":"BF01736225_CR97","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1111\/j.1432-1033.1978.tb12327.x","volume":"86","author":"A Raz","year":"1978","unstructured":"Raz A, Aharony D, Kenig-Wakshal P (1978) Biosynthesis of thromboxane B2 and 12-L-hydroxy-5,8,10-heptadecatrienoic acid in human platelets: evidence for a common enzymatic pathway. Eur J Biochem 86: 447\u2013454","journal-title":"Eur J Biochem"},{"key":"BF01736225_CR98","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1161\/01.CIR.73.6.1300","volume":"73","author":"IAG Reilly","year":"1986","unstructured":"Reilly IAG, Doran J, Smith B, FitzGerald GA (1986) Increased thromboxane biosynthesis in a human model of platelet activation: biochemical and functional consequences of selective inhibition of thromboxane synthase. Circulation 73: 1300\u20131309","journal-title":"Circulation"},{"key":"BF01736225_CR99","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/0049-3848(86)91700-7","volume":"41","author":"IAG Reilly","year":"1986","unstructured":"Reilly IAG, FitzGerald GA (1986) Eicosanoid biosynthesis and platelet function with advancing age. Thromb Res 41: 545\u2013554","journal-title":"Thromb Res"},{"key":"BF01736225_CR100","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1182\/blood.V69.1.180.180","volume":"69","author":"IAG Reilly","year":"1987","unstructured":"Reilly IAG, FitzGerald GA (1987) Inhibition of thromboxane formation in vivo and ex vivo: implications for therapy with platelet inhibitory drugs. Blood 69: 180\u2013186","journal-title":"Blood"},{"key":"BF01736225_CR101","first-page":"1087","volume":"292","author":"IAG Reilly","year":"1986","unstructured":"Reilly IAG, Roy L, FitzGerald GA (1986) Thromboxane biosynthesis is increased in systemic sclerosis with Raynaud's phenomenon. Br Med J 292: 1087\u20131089","journal-title":"Br Med J"},{"key":"BF01736225_CR102","doi-asserted-by":"crossref","first-page":"8384","DOI":"10.1016\/S0021-9258(19)68855-1","volume":"256","author":"LJ Roberts II","year":"1981","unstructured":"Roberts LJ, II, Sweetman BJ, Oates JA (1981) Metabolism of thromboxane B2 in man: identification of twenty urinary metabolites. J Biol Chem 256: 8384\u20138393","journal-title":"J Biol Chem"},{"key":"BF01736225_CR103","doi-asserted-by":"crossref","first-page":"3073","DOI":"10.1073\/pnas.72.8.3073","volume":"72","author":"GJ Roth","year":"1975","unstructured":"Roth GJ, Stanford N, Majerus PW (1975) Acetylation of prostaglandin synthase by aspirin. Proc Natl Acad Sci USA 72: 3073\u20133076","journal-title":"Proc Natl Acad Sci USA"},{"key":"BF01736225_CR104","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1056\/NEJM198908103210603","volume":"321","author":"E Schiff","year":"1989","unstructured":"Schiff E, Peleg E, Goldenberg M, Rosenthal T, Ruppin E, Tamarkin M, Barkai G, Ben-Barugh G, Yahal I, Blankstein J, Goldman B, Mashiach S (1989) The use of aspirin to prevent pregnancy-induced hypertension and lower the ratio of thromboxane A2 to prostacyclin in relatively high risk pregnancies. N Engl J Med 321: 351\u2013356","journal-title":"N Engl J Med"},{"key":"BF01736225_CR105","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1038\/newbio231235a0","volume":"231","author":"JB Smith","year":"1971","unstructured":"Smith JB, Willis AL (1971) Aspirin selectively inhibits prostaglandin production in human platelets. Nature New Biol 231: 235\u2013237","journal-title":"Nature New Biol"},{"key":"BF01736225_CR106","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/0002-9343(86)90289-5","volume":"81","author":"MJ Stampfer","year":"1986","unstructured":"Stampfer MJ, Jakubowski JA, Deykin D, Schafer AI, Willett WC, Hennekens CH (1986) Effect of alternate-day regular and enteric-coated aspirin on platelet aggregation, bleeding time, and thromboxane A2 levels in bleeding blood. Am J Med 81: 400\u2013404","journal-title":"Am J Med"},{"key":"BF01736225_CR107","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/0049-3848(84)90230-5","volume":"35","author":"K Stegmeier","year":"1984","unstructured":"Stegmeier K, Pill J, M\u00fcller-Beckmann B, Schmidt FH, Witte E-C, Wolff H-P, Patscheke H (1984) The pharmacological profile of the thromboxane A2 antagonist BM 13,177 \u2014 A new antiplatelet and antithrombotic compound. Thromb Res 35: 379\u2013395","journal-title":"Thromb Res"},{"key":"BF01736225_CR108","first-page":"1012","volume":"22","author":"K Stegmeier","year":"1985","unstructured":"Stegmeier K, Hartig F, Pill J, Patscheke H (1985) Prevention of glycerol-induced acute renal failure in rabbits by the thromboxane antagonist BM 13,505. Proc. of the European Dialysis and Transplant Association \u2014 European Renal Association 22: 1012\u20131016","journal-title":"Proc. of the European Dialysis and Transplant Association \u2014 European Renal Association"},{"key":"BF01736225_CR109","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/0014-2999(88)90726-1","volume":"152","author":"GTG Swayne","year":"1988","unstructured":"Swayne GTG, Maguire J, Dolan J, Raval P, Greener M, Owen DAA (1988) Evidence for homogeneity of thromboxane A2 receptor using structurally different antagonists. Eur J Pharmacol 152: 311\u2013319","journal-title":"Eur J Pharmacol"},{"key":"BF01736225_CR110","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/S0140-6736(81)91551-8","volume":"I","author":"HM Tyler","year":"1981","unstructured":"Tyler HM, Saxton CAPD, Parry MJ (1981) Administration to man of UK-37,248-01, a selective inhibitor of thromboxane synthetase. Lancet I: 629\u2013632","journal-title":"Lancet"},{"key":"BF01736225_CR111","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0140-6736(86)91891-X","volume":"I","author":"HCS Wallenburg","year":"1986","unstructured":"Wallenburg HCS, Dekker GA, Makovitz JW, Rotmans P (1986) Low-dose aspirin prevents pregnancy-induced hypertension and pre-eclampsia in angiotensin sensitive primigravidae. Lancet I: 1\u20133","journal-title":"Lancet"},{"key":"BF01736225_CR112","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/S0002-9378(85)80223-4","volume":"152","author":"SW Walsh","year":"1985","unstructured":"Walsh SW (1985) Preeclampsia: an imbalance in placental prostacyclin and thromboxane production. Am J Obstet Gynecol 152: 335\u2013340","journal-title":"Am J Obstet Gynecol"},{"key":"BF01736225_CR113","doi-asserted-by":"crossref","first-page":"14847","DOI":"10.1016\/S0021-9258(18)33360-X","volume":"257","author":"T Watanabe","year":"1982","unstructured":"Watanabe T, Narumiya S, Shimizu T, Hayaishi O (1982) Characterization of the biosynthetic pathway of prostaglandin D2 in human platelet-rich plasma. J Biol Chem 257: 14847\u201314852","journal-title":"J Biol Chem"},{"key":"BF01736225_CR114","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1056\/NEJM198304073081402","volume":"308","author":"BB Weksler","year":"1983","unstructured":"Weksler BB, Pett SB, Alonso D, Richter RC, Stelzer P, Subramranian V, Tack-Goldman K, Gay WA (1983) Differential inhibition by aspirin of vascular and platelet prostaglandin synthesis in atherosclerosis patients. N Engl J Med 308: 800\u2013805","journal-title":"N Engl J Med"},{"key":"BF01736225_CR115","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/0006-2952(88)90219-5","volume":"37","author":"H Zehender","year":"1988","unstructured":"Zehender H, Witte E-C, Wolff H-P, Patscheke H (1988) Irreversible inhibition of the TxA2\/PGH2 receptor of human platelets by a photoaffinity ligand. Biochem Pharmacol 37: 491\u2013495","journal-title":"Biochem Pharmacol"},{"key":"BF01736225_CR116","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/0016-5085(83)90133-6","volume":"84","author":"RD Zipser","year":"1983","unstructured":"Zipser RD, Radvan GH, Kronborg IJ, Duke R, Little TE (1983) Urinary thromboxane B2 and prostaglandin E2 in the hepatorenal syndrome: evidence for increased vasoconstrictor and decreased vasodilator factors. Gastroenterology 84: 697\u2013703","journal-title":"Gastroenterology"}],"container-title":["Blut"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF01736225.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF01736225\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF01736225","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,11]],"date-time":"2021-07-11T20:23:15Z","timestamp":1626034995000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF01736225"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1990,5]]},"references-count":116,"journal-issue":{"issue":"5","published-print":{"date-parts":[[1990,5]]}},"alternative-id":["BF01736225"],"URL":"https:\/\/doi.org\/10.1007\/bf01736225","relation":{},"ISSN":["0006-5242","1432-0584"],"issn-type":[{"value":"0006-5242","type":"print"},{"value":"1432-0584","type":"electronic"}],"subject":[],"published":{"date-parts":[[1990,5]]}}}